Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY:BSX)

106.63 +0.16 (+0.15%)
Streaming Delayed Price Updated: 12:55 PM EDT, Jul 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
BOSTON SCIENTIFIC CORP (NYSE:BSX) – A High-Growth Momentum Stock with Strong Technical Setup
Boston Scientific Corp (NYSE:BSX) combines strong earnings momentum, expanding margins, and a bullish technical setup, making it a candidate for high-growth investors. 
Via Chartmill
P/E Ratio Insights for Boston Scientific
 
Via Benzinga
3 Market-Beating Stocks with Competitive Advantages
Stocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on capital. The select few that can do all three for many years are often the... 
Via StockStory
Michael Mahoney Turned Boston Scientific Into A Medical Tech Empire
Michael Mahoney's grandfather was a cardiac surgeon — so his first career plan was to become a doctor. Mahoney didn't give up — he adjusted. 
Via Investor's Business Daily
Boston Scientific Scraps This Aortic Valve, Sticks To 2025 Outlook
Boston Scientific ends global sales of ACURATE valves and halts FDA pursuit, citing rising regulatory burdens; expects to meet 2025 sales. 
Via Benzinga
Boston Scientific Discontinues Worldwide Sales Of Acurate Aortic Valve Systems: But Retail Sentiment Brightens
The company said in a regulatory filing that the decision was made in light of increased clinical and regulatory requirements to maintain regulatory approvals in global markets and to obtain approvals... 
Via Stocktwits
How Boston Scientific's Surprise Setback Bolstered Edwards, Medtronic, Abbott
The company said the regulatory path forward for one of its key systems is too murky to pursue. 
Via Investor's Business Daily
BOSTON SCIENTIFIC CORP (NYSE:BSX) – A Strong Growth Stock with Technical Breakout Potential
Boston Scientific Corp (NYSE:BSX) shows strong growth fundamentals and a bullish technical setup, making it a compelling candidate for growth investors. 
Via Chartmill
Boston Scientific (NYSE:BSX) Q1 Earnings: Leading The Medical Devices & Supplies - Diversified Pack
Let’s dig into the relative performance of Boston Scientific (NYSE:BSX) and its peers as we unravel the now-completed Q1 medical devices & supplies - diversified earnings season. 
Via StockStory
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
$1000 Invested In Boston Scientific 15 Years Ago Would Be Worth This Much Today
 
Via Benzinga
What's going on in today's pre-market session: S&P500 movers
Get insights into the top gainers and losers in the S&P500 index of Tuesday's pre-market session. 
Via Chartmill
BOSTON SCIENTIFIC CORP (NYSE:BSX) – A Strong Growth Candidate Meeting Minervini’s Criteria
BOSTON SCIENTIFIC CORP (NYSE:BSX) meets Minervini’s Trend Template with strong technicals and high growth fundamentals, making it a candidate for momentum investors. 
Via Chartmill
Forecasting The Future: 9 Analyst Projections For Boston Scientific
 
Via Benzinga
BOSTON SCIENTIFIC CORP (NYSE:BSX) – A Strong Technical Setup in a Leading Medical Device Stock
BOSTON SCIENTIFIC CORP (NYSE:BSX) shows strong technicals and a high-quality setup, making it a breakout candidate. The stock has outperformed peers and exhibits bullish patterns with clear support and... 
Via Chartmill
3 Large-Cap Stocks with Solid Fundamentals
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for... 
Via StockStory
Is BOSTON SCIENTIFIC CORP (NYSE:BSX) suited for high growth investing?
A fundamental and technical analysis of (NYSE:BSX): Should you consider BOSTON SCIENTIFIC CORP (NYSE:BSX) for high growth investing? 
Via Chartmill
2 S&P 500 Stocks Worth Investigating and 1 to Avoid
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some... 
Via StockStory
Topics Stocks
$100 Invested In Boston Scientific 15 Years Ago Would Be Worth This Much Today
 
Via Benzinga
3 Stocks Lifting 2025 Guidance Despite Market Jitters
See these three stocks that beat on earnings in Q1 and raised their guidance for the rest of 2025. These stocks are signaling strength amid tough conditions. 
Via MarketBeat
Topics World Trade
2 Profitable Stocks Worth Your Attention and 1 to Keep Off Your Radar
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
GE HealthCare (GEHC) Reports Q1: Everything You Need To Know Ahead Of Earnings
Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) will be reporting earnings tomorrow before market hours. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence World Trade
Align Technology Earnings: What To Look For From ALGN
Dental technology company Align Technology (NASDAQ:ALGN) will be reporting results tomorrow after market close. Here’s what you need to know. 
Via StockStory
Topics Economy World Trade
What To Expect From CONMED’s (CNMD) Q1 Earnings
Medical tech company CONMED (NYSE:CNMD) will be reporting earnings tomorrow after market close. Here’s what you need to know. 
Via StockStory
Topics World Trade
Is BOSTON SCIENTIFIC CORP (NYSE:BSX) following the Minervini trend for explosive growth?
A fundamental and technical analysis of (NYSE:BSX): Delving into BOSTON SCIENTIFIC CORP (NYSE:BSX)'s high Growth Prospects. 
Via Chartmill
BSX Q1 Earnings Call: Outperformance Driven by Cardiology and Electrophysiology, Guidance Raised Amid Tariff Headwinds
Medical device company Boston Scientific (NYSE:BSX) announced better-than-expected revenue in Q1 CY2025, with sales up 20.9% year on year to $4.66 billion. The company expects next quarter’s revenue to... 
Via StockStory
Topics World Trade
Boston Scientific Analysts Boost Their Forecasts Following Upbeat Results
 
Via Benzinga
Why Boston Scientific (BSX) Stock Is Up Today
Shares of medical device company Boston Scientific (NYSE:BSX) jumped 8.5% in the pre-market session after the company reported first quarter 2025 results that beat analysts' sales and EPS expectations.... 
Via StockStory
Topics Artificial Intelligence
Stocks Surge On China Tariff Hopes, Tesla Jumps, Gold Loses Shine: What's Driving Markets Wednesday?
Risk-on sentiment dominated Wall Street on Wednesday, as upbeat earnings reports and conciliatory messages from the Trump administration helped lift investor confidence. 
Via Benzinga
Topics Government
Boston Scientific Stock Jumps On Strong Q1 Earnings, Upbeat Full-Year Guidance: But Retail’s Unmoved
CEO Mike Mahoney said that the company remains “well-positioned” for the future after an “exceptional quarter.” 
Via Stocktwits
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.